These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9654265)

  • 21. Treatment of chronic angina pectoris with combination mibefradil and beta-blocker therapy.
    Alpert JS
    Clin Cardiol; 1998 Feb; 21(2):129. PubMed ID: 9491954
    [No Abstract]   [Full Text] [Related]  

  • 22. Rhabdomyolysis secondary to interaction of fusidic acid and simvastatin.
    Yuen SL; McGarity B
    Med J Aust; 2003 Aug; 179(3):172. PubMed ID: 12885276
    [No Abstract]   [Full Text] [Related]  

  • 23. Mibefradil--a new calcium-channel blocker.
    Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the safety and efficacy of mibefradil and nifedipine SR in patients with renal disease and hypertension.
    Woittiez AJ; Huysmans FT; Bailey R; Robson RA; Mion Júnior D; Villa G; Kobrin I
    Clin Nephrol; 1998 Mar; 49(3):160-6. PubMed ID: 9543597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What lessons can be learnt from withdrawal of mibefradil from the market?
    Po AL; Zhang WY
    Lancet; 1998 Jun; 351(9119):1829-30. PubMed ID: 9652662
    [No Abstract]   [Full Text] [Related]  

  • 26. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
    Rogers R; Prpic R
    Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhabdomyolysis in prostate cancer--caution in prescribing cyproterone acetate with statins.
    Ahamed E; Bissett D
    Clin Oncol (R Coll Radiol); 2004 Dec; 16(8):528-9. PubMed ID: 15630845
    [No Abstract]   [Full Text] [Related]  

  • 28. [88 years old woman with acute muscular weakness and diffuse muscular pain: have you thought about the drugs?].
    Arnold Ch; Lamy O; Hagmann N
    Praxis (Bern 1994); 2010 Dec; 99(24):1507-11. PubMed ID: 21125536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mibefradil (Posicor) induced sinus arrest.
    Sanders P; Walker J; Craig RJ; Hii JT; Steele PM
    Aust N Z J Med; 1998 Dec; 28(6):836-7. PubMed ID: 9972419
    [No Abstract]   [Full Text] [Related]  

  • 30. Mibefradil and an effective formulary system.
    Vermeulen LC; Dunham DB
    Am J Health Syst Pharm; 1998 Sep; 55(18):1934-5. PubMed ID: 9784776
    [No Abstract]   [Full Text] [Related]  

  • 31. Sildenafil-simvastatin interaction: possible cause of rhabdomyolysis?
    Gutierrez CA
    Am Fam Physician; 2001 Feb; 63(4):636-7. PubMed ID: 11237079
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic and therapeutic differences among calcium channel antagonists: profile of mibefradil, a new calcium antagonist.
    Triggle DJ
    Am J Cardiol; 1996 Nov; 78(9A):7-12. PubMed ID: 8903279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of mibefradil in subgroups of patients with chronic stable angina pectoris.
    Charlon V; Kobrin I
    Int J Clin Pract; 1998 Jun; 52(4):257-64. PubMed ID: 9744152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating the safety of mibefradil, a selective T-type calcium antagonist, in patients with chronic congestive heart failure.
    van der Vring JA; Bernink PJ; van der Wall EE; van Velhuisen DJ; Braun S; Kobrin I
    Clin Ther; 1996; 18(6):1191-206. PubMed ID: 9001836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1998 Feb; 279(5):346. PubMed ID: 9459455
    [No Abstract]   [Full Text] [Related]  

  • 36. Mibefradil: a new twist to the calcium channel antagonist.
    Lynn MM
    Nurse Pract; 1998 May; 23(5):100, 102-4, 106-7. PubMed ID: 9614683
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful re-challenge of daptomycin therapy after initial rhabdomyolysis with co-administration of simvastatin.
    Bland CM; Bookstaver PB; Thomas S
    Int J Antimicrob Agents; 2011 Dec; 38(6):549-50. PubMed ID: 21958456
    [No Abstract]   [Full Text] [Related]  

  • 38. The short life and rapid death of a novel antihypertensive and antianginal agent.
    Krum H; McNeil JJ
    Med J Aust; 1998 Oct; 169(8):408-9. PubMed ID: 9830386
    [No Abstract]   [Full Text] [Related]  

  • 39. Withdrawal of Posicor from market.
    SoRelle R
    Circulation; 1998 Sep; 98(9):831-2. PubMed ID: 9738634
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of mibefradil in hypertensive patients with obstructive sleep apnea.
    Heitmann J; Grote L; Knaack L; Köhler U; Hinder M; Peter JH
    Eur J Clin Pharmacol; 1998; 54(9-10):691-6. PubMed ID: 9923569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.